Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Pharmacotherapy of Epilepsy in Children

February 27, 2019 (Noon–1:15 p.m. ET)

Sponsor/Co-Sponsor(s)

Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act, NICHD

Purpose

This presentation will focus on the current approach to treating pediatric epilepsy in children, with specific attention to the key clinical pharmacology issues of antiepileptic medication selection and management in children.

Presenter Tracy Glauser, M.D., will address the following objectives:

  • Describe the classification of seizure types and epilepsy syndromes and its effect on medication selection for children with epilepsy.
  • Understand the pharmacokinetic and pharmacodynamic variability associated with antiepileptic medications.
  • Understand the importance of clinical pharmacology in medication management and ultimate outcome.

Dr. Glauser is a professor of pediatrics and neurology, director of the Comprehensive Epilepsy Center, and co-founder of the Genetic Pharmacology Service at the Cincinnati Children’s Hospital Medical Center.

Contact

George Giacoia, OPPTB, NICHD
Phone: 301–496–5589
Email: giacoiag@mail.nih.gov

Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.
top of page BACK TO TOP